Watch all Cannes Winners 2026 cases and analysis

    6% → 9%

    StatBrand Strategy

    GLP-1 use among weight-loss consumers jumped from 6% to 9% in a year

    9% of consumers trying to lose weight take GLP-1 drugs, up from 6% in 2024 - a 50% relative jump in one year. Once taboo or clinical-only treatments are moving mainstream, and adjacent categories are already adapting: Nestlé's Boost launched a pre-meal protein shot formulated for GLP-1 users' appetite control.

    Source

    Euromonitor International, Top Global Consumer Trends 2026 (2025)

    Euromonitor International (Ali Angus, Jana Rude et al.)

    pp. 26, 32, Health and Nutrition Survey 2024 (n=9,886) and 2025 (n=9,022)

    Go to the original